KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Shares Issued (2016 - 2018)

Cme (CME) has disclosed Shares Issued for 10 consecutive years, with $1.4 million as the latest value for Q4 2018.

  • On a quarterly basis, Shares Issued fell 77.78% to $1.4 million in Q4 2018 year-over-year; TTM through Dec 2018 was $11.5 million, a 68.66% decrease, with the full-year FY2018 number at $11.5 million, down 68.66% from a year prior.
  • Shares Issued was $1.4 million for Q4 2018 at Cme, down from $1.9 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $28.6 million in Q1 2015 to a low of $1.4 million in Q4 2018.
  • A 5-year average of $9.9 million and a median of $9.5 million in 2016 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: skyrocketed 535.56% in 2015, then crashed 77.78% in 2018.
  • Cme's Shares Issued stood at $4.5 million in 2014, then skyrocketed by 171.11% to $12.2 million in 2015, then soared by 82.79% to $22.3 million in 2016, then plummeted by 71.75% to $6.3 million in 2017, then plummeted by 77.78% to $1.4 million in 2018.
  • Per Business Quant, the three most recent readings for CME's Shares Issued are $1.4 million (Q4 2018), $1.9 million (Q3 2018), and $4.0 million (Q2 2018).